BioCentury

7:00 AM GMT, Apr 11, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Status

Vemurafenib: Phase Ib started

Roche began an open-label, dose-escalation, international Phase Ib trial to evaluate oral vemurafenib plus oral

Read the full 158 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.